source-backed-method-package90/100
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial methods
derin b keskin
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
humanMethods-Backed
20180 equipment8 steps